“…The species Acinetobacter baumannii , in particular, is known to cause nosocomial infections, such as endocarditis, meningitis, pneumonia, septicaemia, and tract infection [1]. Some Acinetobacter bacteria were reported to produce secondary metabolites, mainly including siderophores acinetobactin [2], acinetoferrin [3], baumannoferrins A and B [4], polysaccharides [5,6,7], antibacterial succinamide conjugate diacid [8], antifungal volatile compounds [1], and antimicrobial diketopiperazines cyclo-(proline-leucine) and cyclo-(proline-tyrosine) [9]. However, it is our understanding that no natural product has yet been reported from marine-derived Acinetobacter species.…”